Pfizer has agreed to sell its entire shareholding in Capsugel Healthcare to Chester Holdings – an affiliate of the private equity firm Kohlberg Kravis Roberts (KKR). The deal is valued at approximately US$2.4 billion.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.